Percutaneous transluminal angioplasty: Association between depressive symptoms and diminished health status benefits

Vascular Medicine

Volumn 16, Issue 4, 2011, Pages 260-266

  Smolderen, Kim G ^a,b   Safley, David M ^a,c   House, John A ^a   Spertus, John A ^a,c   Marso, Steven P ^a,c  

^a Heart and Vascular Institute   (United States)

^b TILBURG UNIVERSITY   (Netherlands)

^c UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

Author keywords

angioplasty; depression; health status; peripheral vascular disease; revascularization

Indexed keywords

AGED; ARTICLE; CROSS-SECTIONAL STUDY; DEPRESSION; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; FOLLOW UP; HEALTH STATUS; HUMAN; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRIORITY JOURNAL; QUESTIONNAIRE; RATING SCALE; REVASCULARIZATION;

AGED; ANGIOPLASTY, BALLOON; CROSS-SECTIONAL STUDIES; DEPRESSION; FEMALE; HEALTH STATUS; HUMANS; LINEAR MODELS; MALE; MIDDLE AGED; MISSOURI; PATIENT SATISFACTION; PERIPHERAL ARTERIAL DISEASE; PROSPECTIVE STUDIES; QUALITY OF LIFE; QUESTIONNAIRES; RECOVERY OF FUNCTION; REGISTRIES; RISK ASSESSMENT; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SOCIAL BEHAVIOR; TIME FACTORS; TREATMENT OUTCOME;

EID: 80051647963     PISSN: 1358863X     EISSN: 14770377     Source Type: Journal    
DOI: 10.1177/1358863X11415568     Document Type: Article

References (30)

1. Criqui MH, Denenberg JO, Langer RD, Fronek A. The epidemiology of peripheral arterial disease: importance of identifying the population at risk. Vasc Med. 1997 ; 2: 221-226 (Pubitemid 27468155)
2. McDermott MM, Greenland P, Liu K, et al. Leg symptoms in peripheral arterial disease. Associated clinical characteristics and functional impairment. JAMA. 2001 ; 286: 1599-1606 (Pubitemid 33010284)
3. Arseven A, Guralnik JM, O'Brien E, Liu K, McDermott M. Peripheral arterial disease and depressed mood in older men and women. Vasc Med. 2001 ; 6: 229-234 (Pubitemid 34256762)
4. McDermott MM, Greenland P, Guralnik JM, et al. Depressive symptoms and lower extremity functioning in men and women with peripheral arterial disease. J Gen Intern Med. 2003 ; 18: 461-467 (Pubitemid 36836675)
5. Smolderen KG, Aquarius AE, de Vries J, Smith OR, Hamming JF, Denollet J. Depressive symptoms in peripheral arterial disease: a follow-up study on prevalence, stability, and risk factors. J Affect Disord. 2008 ; 110: 27-35
6. Ruo B, Liu K, Tian L, et al. Persistent depressive symptoms and functional decline among patients with peripheral arterial disease. Psychosom Med. 2007 ; 69: 415-424 (Pubitemid 46987884)
7. Cherr G, Zimmerman P, Wang J, Dosluoglu H. Patients with depression are at increased risk for secondary cardiovascular events after lower extremity revascularization. J Gen Intern Med. 2008 ; 23: 629-634
8. Anderson PL, Gelijns A, Moskowitz A, et al. Understanding trends in inpatient surgical volume: vascular interventions, 1980-2000. J Vasc Surg. 2004 ; 39: 1200-1208 (Pubitemid 38952586)
9. Bosch JL, van der Graaf Y, Hunink MG. Health-related quality of life after angioplasty and stent placement in patients with iliac artery occlusive disease: results of a randomized controlled clinical trial. Circulation. 1999 ; 99: 3155-3160 (Pubitemid 29289081)
10. Safley DM, House JA, Laster SB, Daniel WC, Spertus JA, Marso SP. Quantifying improvement in symptoms, functioning, and quality of life after peripheral endovascular revascularization. Circulation. 2007 ; 115: 569-575 (Pubitemid 46226166)
11. Mallik S, Krumholz HM, Lin ZQ, Kasl ZV, Mattera JA, Roumains SA. Patients with depressive symptoms have lower health status benefits after coronary bypass surgery. Circulation. 2005 ; 111: 271-277 (Pubitemid 40165332)
12. Kamphuis MH, Geerlings MI, Giampaoli S, Nissinen A, Grobbee DE, Kromhout D. The association of depression with cardiovascular mortality is partly explained by health status. J Affect Disord. 2009 ; 114: 184-192
13. Norgren L, Hiatt WR, Dormandy JA, et al. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). Eur J Vasc Endovasc Surg. 2007 ; 33 (suppl 1). S1-75
14. Spitzer RL, Williams JB, Kroenke K, et al. Utility of a new procedure for diagnosing mental disorders in primary care. JAMA. 1994 ; 272: 1749-1756 (Pubitemid 24372002)
15. Diagnostic and statistical manual of mental disorders, fourth edition (DSM-IV). Washington, DC: American Psychiatric Publishing ; 1994 :
16. Lichtman JH, Bigger JT, Blumenthal JA, et al. Depression and coronary heart disease. Recommendations for screening, referral, and treatment. A Science Advisory from the American Heart Association Prevention Committee of the Council on Cardiovascular Nursing, Council on Clinical Cardiology, Council on Epidemiology and Prevention, and Interdisciplinary Council on Quality of Care and Outcomes Research. Circulation. 2008 ; 118: 1768-1775
17. Spitzer RL, Kroenke K, Williams JB. Validation and utility of a self-report version of PRIME-MD: the PHQ primary care study. Primary Care Evaluation of Mental Disorders. Patient Health Questionnaire. JAMA. 1999 ; 282: 1737-1744 (Pubitemid 29533604)
18. Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001 ; 16: 606-613 (Pubitemid 32823891)
19. Lowe B, Schenkel I, Carney-Doebbeling C, Gobel C. Responsiveness of the PHQ-9 to psychopharmacological depression treatment. Psychosomatics. 2006 ; 47: 62-67 (Pubitemid 43017122)
20. Spertus J, Jones P, Poler S, Rocha-Singh K. The Peripheral Artery Questionnaire: a new disease-specific health status measure for patients with peripheral arterial disease. Am Heart J. 2004 ; 147: 301-308 (Pubitemid 38180531)
21. Spertus J, Decker C, Woodman C, et al. Effect of difficulty affording health care on health status after coronary revascularization. Circulation. 2005 ; 111: 2572-2578 (Pubitemid 40740855)
22. Cohen J Statistical power analysis for the behavioral sciences. Hillsdale, NJ: Erlbaum ; 1988 :
23. Sloan J, Symonds T, Vargas-Chanes D, Fridley B. Practical guidelines for assessing the clinical significance of health-related quality of life changes with clinical trials. Drug Inf J. 2003 ; 37: 23-31 (Pubitemid 37305150)
24. Thomas AJ, Kalaria RN, O'Brien JT. Depression and vascular disease: what is the relationship?. J Affect Disord. 2004 ; 79: 81-95 (Pubitemid 38340532)
25. Morgan AL, Masoudi FA, Havranek EP, et al. Difficulty taking medications, depression, and health status in heart failure patients. J Card Fail. 2006 ; 12: 54-60 (Pubitemid 43267752)
26. Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med. 2006 ; 3: e442
27. Rollman BL, Belnap BH, LeMenager MS, et al. Telephone-delivered collaborative care for treating post-CABG depression: a randomized controlled trial. JAMA. 2009 ; 302: 2095-2103
28. Swenson JR, O'Connor CM, Barton D, et al. Influence of depression and effect of treatment with sertraline on quality of life after hospitalization for acute coronary syndrome. Am J Cardiol. 2003 ; 92: 1271-1276 (Pubitemid 37431133)
29. Rumsfeld JS, Havranek E, Masoudi FA, et al. Depressive symptoms are the strongest predictors of short-term declines in health status in patients with heart failure. J Am Coll Cardiol. 2003 ; 42: 1811-1817 (Pubitemid 37433663)
30. Koenig H. Depression in hospitalized older patients with congestive heart failure. Gen Hosp Psychiatry. 1998 ; 20: 29-43 (Pubitemid 28109986)